Literature DB >> 20671181

Dopaminergic network differences in human impulsivity.

Joshua W Buckholtz1, Michael T Treadway, Ronald L Cowan, Neil D Woodward, Rui Li, M Sib Ansari, Ronald M Baldwin, Ashley N Schwartzman, Evan S Shelby, Clarence E Smith, Robert M Kessler, David H Zald.   

Abstract

Dopamine (DA) has long been implicated in impulsivity, but the precise mechanisms linking human variability in DA signaling to differences in impulsive traits remain largely unknown. By using a dual-scan positron emission tomography approach in healthy human volunteers with amphetamine and the D2/D3 ligand [18F]fallypride, we found that higher levels of trait impulsivity were predicted by diminished midbrain D2/D3 autoreceptor binding and greater amphetamine-induced DA release in the striatum, which was in turn associated with stimulant craving. Path analysis confirmed that the impact of decreased midbrain D2/D3 autoreceptor availability on trait impulsivity is mediated in part through its effect on stimulated striatal DA release.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20671181      PMCID: PMC3161413          DOI: 10.1126/science.1185778

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  8 in total

1.  Impulsive and premeditated aggression: a factor analysis of self-reported acts.

Authors:  E S Barratt; M S Stanford; L Dowdy; M J Liebman; T A Kent
Journal:  Psychiatry Res       Date:  1999-05-31       Impact factor: 3.222

2.  Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse.

Authors:  Nadine M Lambert; Marsha McLeod; Susan Schenk
Journal:  Addiction       Date:  2006-05       Impact factor: 6.526

3.  The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.

Authors:  M Santiago; B H Westerink
Journal:  Eur J Pharmacol       Date:  1991-10-29       Impact factor: 4.432

4.  L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease.

Authors:  Roshan Cools; Roger A Barker; Barbara J Sahakian; Trevor W Robbins
Journal:  Neuropsychologia       Date:  2003       Impact factor: 3.139

Review 5.  Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies.

Authors:  Antonio Verdejo-García; Andrew J Lawrence; Luke Clark
Journal:  Neurosci Biobehav Rev       Date:  2008-01-17       Impact factor: 8.989

6.  Impulsive behavior in adults with attention deficit/ hyperactivity disorder: characterization of attentional, motor and cognitive impulsiveness.

Authors:  L Malloy-Diniz; D Fuentes; W Borges Leite; H Correa; A Bechara
Journal:  J Int Neuropsychol Soc       Date:  2007-05-18       Impact factor: 2.892

7.  Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement.

Authors:  Jeffrey W Dalley; Tim D Fryer; Laurent Brichard; Emma S J Robinson; David E H Theobald; Kristjan Lääne; Yolanda Peña; Emily R Murphy; Yasmene Shah; Katrin Probst; Irina Abakumova; Franklin I Aigbirhio; Hugh K Richards; Young Hong; Jean-Claude Baron; Barry J Everitt; Trevor W Robbins
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

8.  Relationship between craving and personality in treatment-seeking women with substance-related disorders.

Authors:  Monica L Zilberman; Hermano Tavares; Nady el-Guebaly
Journal:  BMC Psychiatry       Date:  2003-01-13       Impact factor: 3.630

  8 in total
  255 in total

1.  Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Impulsivity and the modular organization of resting-state neural networks.

Authors:  F Caroline Davis; Annchen R Knodt; Olaf Sporns; Benjamin B Lahey; David H Zald; Bart D Brigidi; Ahmad R Hariri
Journal:  Cereb Cortex       Date:  2012-05-29       Impact factor: 5.357

3.  Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.

Authors:  Dara G Ghahremani; Buyean Lee; Chelsea L Robertson; Golnaz Tabibnia; Andrew T Morgan; Natalie De Shetler; Amira K Brown; John R Monterosso; Adam R Aron; Mark A Mandelkern; Russell A Poldrack; Edythe D London
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

4.  Striatal sensitivity during reward processing in attention-deficit/hyperactivity disorder.

Authors:  Yannis Paloyelis; Mitul A Mehta; Stephen V Faraone; Philip Asherson; Jonna Kuntsi
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-06-05       Impact factor: 8.829

Review 5.  Molecular imaging and neural networks in impulse control disorders in Parkinson's disease.

Authors:  I Aracil-Bolaños; A P Strafella
Journal:  Parkinsonism Relat Disord       Date:  2015-08-12       Impact factor: 4.891

6.  Stability and change in risk-taking propensity across the adult life span.

Authors:  Anika K Josef; David Richter; Gregory R Samanez-Larkin; Gert G Wagner; Ralph Hertwig; Rui Mata
Journal:  J Pers Soc Psychol       Date:  2016-01-28

7.  In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO.

Authors:  I Boileau; D Payer; B Chugani; D S S Lobo; S Houle; A A Wilson; J Warsh; S J Kish; M Zack
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

8.  Are rash impulsive and reward sensitive traits distinguishable? A test in young adults.

Authors:  Adrienne L Romer; Valerie F Reyna; Seth T Pardo
Journal:  Pers Individ Dif       Date:  2016-05-21

9.  Individual differences in dopamine D2 receptor availability correlate with reward valuation.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jaime J Castrellon; Scott F Perkins; Ronald L Cowan; David H Zald
Journal:  Cogn Affect Behav Neurosci       Date:  2018-08       Impact factor: 3.282

10.  Phasic mesolimbic dopamine signaling encodes the facilitation of incentive motivation produced by repeated cocaine exposure.

Authors:  Sean B Ostlund; Kimberly H LeBlanc; Alisa R Kosheleff; Kate M Wassum; Nigel T Maidment
Journal:  Neuropsychopharmacology       Date:  2014-05-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.